{
    "Trade/Device Name(s)": [
        "MicroScan MICroSTREP plus Panel",
        "Microdilution Minimum Inhibitory Concentration (MIC) Panels",
        "MicroScan MICroSTREP plus Panel Cefepime"
    ],
    "Submitter Information": "Dade Behring Inc.",
    "510(k) Number": "K063099",
    "Predicate Device Reference 510(k) Number(s)": [
        "K021188"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LRG",
        "LTT"
    ],
    "Summary Letter Date": "October 4, 2006",
    "Summary Letter Received Date": "October 11, 2006",
    "Submission Date": "October 4, 2006",
    "Regulation Number(s)": [
        "21CFR866.1640"
    ],
    "Regulation Name(s)": [
        "Antimicrobial susceptibility test powder"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Cefepime"
    ],
    "Specimen Type(s)": [
        "Colonies grown on solid media of aerobic streptococci"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "MicroScan WalkAway instrument"
    ],
    "Method(s)/Technology(ies)": [
        "Broth dilution susceptibility test",
        "Instrument read method",
        "Manual visual read"
    ],
    "Methodologies": [
        "Antimicrobial susceptibility testing",
        "Broth dilution"
    ],
    "Submission Type(s)": [
        "Panel"
    ],
    "Document Summary": "FDA 510(k) summary for MicroScan MICroSTREP plus Panel for determination of Cefepime susceptibility in aerobic streptococci using broth dilution and WalkAway instrument read method",
    "Indications for Use Summary": "Used to determine quantitative and/or qualitative antimicrobial agent susceptibility of colonies of aerobic streptococci including Streptococcus pneumoniae, using Cefepime at concentrations of 0.015\u20138 mcg/ml via manual or instrument read",
    "fda_folder": "Microbiology"
}